Compositions of protein receptor tyrosine kinase inhibitors

Details for Australian Patent Application No. 2009333537 (hide)

Owner VM Pharma LLC

Inventors Wu, Jay Jie-Qiang; Wang, Ling

Agent Baldwins

Pub. Number AU-A-2009333537

PCT Pub. Number WO2010/077680

Priority 61/120,827 08.12.08 US

Filing date 8 December 2009

Wipo publication date 8 July 2010

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

28 July 2011 PCT application entered the National Phase

  PCT publication WO2010/077680 Priority application(s): WO2010/077680

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009333538-Topically active steroids for use in radiation and chemotherapeutics injury

2009333536-Rethermalizing apparatus